Replication data for: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India
Principal Investigator(s): View help for Principal Investigator(s) Mark Duggan; Craig Garthwaite; Aparajita Goyal
Version: View help for Version V1
| Name | File Type | Size | Last Modified |
|---|---|---|---|
| data | 10/12/2019 02:36:AM | ||
|
|
text/plain | 14.6 KB | 10/11/2019 10:36:PM |
Project Citation:
Duggan, Mark, Garthwaite, Craig, and Goyal, Aparajita. Replication data for: The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India. Nashville, TN: American Economic Association [publisher], 2016. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-10-12. https://doi.org/10.3886/E113010V1
Project Description
Summary:
View help for Summary
In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent, with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market. (JEL K33, L11, L13, L65, O14, O34, O38)
Scope of Project
JEL Classification:
View help for JEL Classification
K33 International Law
L11 Production, Pricing, and Market Structure; Size Distribution of Firms
L13 Oligopoly and Other Imperfect Markets
L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics
O14 Industrialization; Manufacturing and Service Industries; Choice of Technology
O34 Intellectual Property and Intellectual Capital
O38 Technological Change: Government Policy
K33 International Law
L11 Production, Pricing, and Market Structure; Size Distribution of Firms
L13 Oligopoly and Other Imperfect Markets
L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics
O14 Industrialization; Manufacturing and Service Industries; Choice of Technology
O34 Intellectual Property and Intellectual Capital
O38 Technological Change: Government Policy
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.